Chugai’s Q1 Profit Drops by Half in Pullback from Alexion Settlement Gain

April 28, 2023
Chugai Pharmaceutical said on April 27 that its January-March operating profit fell by nearly 50% due to the impact of a one-time gain booked a year before after it received a single settlement fee from AstraZeneca’s Alexion over their patent...read more